The Veeda Clinical Research Limited IPO Date Will Be Updated Soon. Read the post to learn about Veeda Clinical Research Limited IPO GMP.
Veeda Clinical Research Limited, formed in 1989, is anon-bank fiscal institution that specializes in furnishing loan backing to depressed families and businesses.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of Veeda Clinical Research Limited IPO:
Bidding Dates
Coming Soon
Price Range
₹0 per share
Face Value
₹0 per share
GMP
₹0
Veeda Clinical Research Limited GMP
The Veeda Clinical Research Limited IPO Today GMP is ₹[].
Veeda Clinical Research Limited IPO Overview
Veeda Clinical Research Ltd, a bioavailability and bioequivalence exploration establishment, issued a draft red herring prospectus( DRHP) in September 2021. SEBI has formally handed in its reflections and authorization for the IPO in December 2021. tus (DRHP) in September 2021. SEBI has already given its observations and approval for the IPO in December 2021.
Generally, the IPOs are approved by SEBI within 2 to 3 months unless there are other queries or interpretations that the controller has. Veeda Clinical Research Ltd IPO will be a combination of a fresh issue and an offer for trade, still the business must first finalizeVeeda Clinical Research Ltd, a bioavailability and bioequivalence exploration establishment, issued a draft red herring prospectus( DRHP) in September 2021. its issue date and price before pacing with the IPO process.
Veeda Clinical Research Limited IPO Financials
Particulars (in Rs. Crores) | FY21 | FY20 | FY19 |
Revenue | 19.58 | 15.13 | 21.84 |
EBITDA | 6.67 | 1.94 | 8.82 |
PAT | 6.33 | 0.0 | 4.42 |
EPS (basic in Rs.) | 15.39 | -0.01 | 12.17 |
ROE | 37.16% | -0.05% | 50.20% |
ROCE | 26.72% | 3.42% | 75.94% |
Cash generated from operating activities | 7.66 | 0.91 | 8.20 |
Net cash from investing activities | -9.26 | -0.90 | -0.93 |
Net cash flow from financing activities | 1.71 | -0.34 | -6.14 |
Net increase in cash and cash equivalents | 0.11 | -0.33 | 1.13 |
Company Profile
Veeda Clinical Research Limited services guests in North America, Europe, and Asia, covering the maturity of the pharmaceutical development and launch value chain. Bioanalytical services, similar as bioavailability and bioequivalence( “ BA and BE ”) examinations, are handed, as is a comprehensive suite of clinical trials, including pre-clinical, early- phase, and late- phase clinical trials and ancillary services. As of March 31, 2021, they’ve expanded from a single installation in Ahmedabad with 62 beds and a yearly capacity of 7,000 samples to four installations in Ahmedabad and one in Mehsana with 532 beds and a yearly capacity of 100,000 samples.
They presently have pre-clinical trial capabilities with two installations in Bangalore, each with 99 separate trial apartments and tone- contained chemistry, biopharmaceutical, and logical laboratories. They’ve conducted pharmacokinetic( “ PK “) examinations as well as general, new chemical realities( “ NCEs “), giant motes, and biosimilar trials.
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Veeda Clinical Research Limited FAQs
When will the Veeda Clinical Research Limited IPO allotment be available?
Details are not available.
What will be the Veeda Clinical Research Limited IPO lot size?
Details are not available.
When will Veeda Clinical Research Limited IPO open for subscription?
Details are not available.
What minimum lot size can retail investors subscribe to?
Retail investors can apply for a minimum of one lot.
When will Veeda Clinical Research Limited IPO list on exchanges?
Details are not available. Usually, it takes ten working days from the last day of subscription to finally list the IPOs on the stock exchanges.
What is the size of Veeda Clinical Research Limited IPO?
Details are not available.
How will I receive shares?
Your shares will get credited directly to your Demat account.
Is it necessary to approve a UPI mandate request immediately?
Approving the UPI payment is the final step of the IPO application. You will get T+1 days to approve the payment mandate in your UPI id.
What is the minimum order quantity for Veeda Clinical Research Limited IPO?
Details are not available.
Leave a Reply